News

Scottish biotechnology centre achieves 300 member milestone ahead of major event
Lesley Parsons Lesley Parsons

Scottish biotechnology centre achieves 300 member milestone ahead of major event

Scotland’s Industrial Biotechnology Innovation Centre (IBioIC) has seen its membership surge to more than 300 after welcoming around 100 new members to its network in 2024.

Industry leaders said the growth reflected the health of Scotland’s bio-economy, with start-ups Vaste and Seastex recently joining IBioIC and helping to push its network past the milestone figure.

Source: The Scotsman

Read More
How Edinburgh pioneer behind 'holy grail' gene therapy technology raised £3 million
Lesley Parsons Lesley Parsons

How Edinburgh pioneer behind 'holy grail' gene therapy technology raised £3 million

An Edinburgh-based biotech pioneer behind technology described as the “holy grail for emerging gene therapies” has been given a £3 million funding injection.

Concinnity Genetics - co-founded by Jessica Birt and Matthew Dale - has developed novel control mechanisms using a cutting-edge artificial intelligence (AI) platform and its synthetic biology expertise.

Source: The Scotsman

Read More
Cytomos secures £5 million for scale-up
Lesley Parsons Lesley Parsons

Cytomos secures £5 million for scale-up

Midlothian-based biotechnology company Cytomos has secured £5 million to scale up production of its cell analysis technology.

Cytomos said that the investment will enable it to drive sales of its first commercial product, Celledonia™, built on its cell analysis technology platform, AuraCyt, which is “already generating significant market traction.”

Read More
Cytomos secures £5 million of scale-up investment
Lesley Parsons Lesley Parsons

Cytomos secures £5 million of scale-up investment

Cytomos has raised £5m to scale up production of its cell analysis technology.

New investment will allow the Edinburgh-based biotechnology company to drive sales of its first commercial product, Celledonia, built on its cell-analysis technology platform AuraCyt.

Source: Business Insider

Read More